{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:29:22Z","timestamp":1790674162061,"version":"4.1.0"},"reference-count":173,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.euroneuro.2022.10.008","type":"journal-article","created":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T23:25:42Z","timestamp":1667863542000},"page":"45-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Ayahuasca's therapeutic potential: What we know \u2013 and what not"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9931-1938","authenticated-orcid":false,"given":"Lucas Oliveira","family":"Maia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9352-2873","authenticated-orcid":false,"given":"Dimitri","family":"Daldegan-Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1653-2565","authenticated-orcid":false,"given":"Isabel","family":"Wie\u00dfner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6934-2485","authenticated-orcid":false,"given":"Draulio B.","family":"Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds Fernando","family":"T\u00f3foli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2022.10.008_bib0001","doi-asserted-by":"crossref","DOI":"10.1177\/2050324520974484","article-title":"2019: A year of expansion in psychedelic research, industry, and deregulation","volume":"6","author":"Aday","year":"2020","journal-title":"Drug Sci. Policy Law"},{"issue":"8","key":"10.1016\/j.euroneuro.2022.10.008_bib0002","doi-asserted-by":"crossref","first-page":"pyv039","DOI":"10.1093\/ijnp\/pyv039","article-title":"Serotonergic psychedelics temporarily modify information transfer in humans","volume":"18","author":"Alonso","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"7","key":"10.1016\/j.euroneuro.2022.10.008_bib0003","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/dar.12985","article-title":"Exploring ayahuasca-assisted therapy for addiction: A qualitative analysis of preliminary findings among an Indigenous community in Canada","volume":"38","author":"Argento","year":"2019","journal-title":"Drug Alcohol Rev."},{"issue":"7-8","key":"10.1016\/j.euroneuro.2022.10.008_bib0004","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/dta.1383","article-title":"Health status of ayahuasca users","volume":"4","author":"Barbosa","year":"2012","journal-title":"Drug Test Anal."},{"issue":"3","key":"10.1016\/j.euroneuro.2022.10.008_bib0005","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/02791072.2009.10400530","article-title":"A six-month prospective evaluation of personality traits, psychiatric symptoms and quality of life in ayahuasca-na\u00efve subjects","volume":"41","author":"Barbosa","year":"2009","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0006","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.comppsych.2016.09.003","article-title":"Psychological and neuropsychological assessment of regular hoasca users","volume":"71","author":"Barbosa","year":"2016","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0007","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3389\/fpsyt.2018.00136","article-title":"Assessment of alcohol and tobacco use disorders among religious users of Ayahuasca","volume":"9","author":"Barbosa","year":"2018","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0008","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3389\/fnins.2018.00536","article-title":"N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function","volume":"12","author":"Barker","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0009","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/7854_2017_474","article-title":"Classic hallucinogens and mystical experiences: phenomenology and neural correlates","author":"Barrett","year":"2017","journal-title":"Behav. Neurobiol. Psychedelic Drugs"},{"issue":"4","key":"10.1016\/j.euroneuro.2022.10.008_bib0010","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/02791072.2019.1607956","article-title":"Short-term treatment effects of a substance use disorder therapy involving traditional Amazonian medicine","volume":"51","author":"Berlowitz","year":"2019","journal-title":"J. Psychoactive Drugs"},{"issue":"8","key":"10.1016\/j.euroneuro.2022.10.008_bib0011","doi-asserted-by":"crossref","first-page":"e42421","DOI":"10.1371\/journal.pone.0042421","article-title":"Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of Ayahuasca: a longitudinal study","volume":"7","author":"Bouso","year":"2012","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.euroneuro.2022.10.008_bib0012","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s40263-020-00748-y","article-title":"Psychedelic treatments for psychiatric disorders: a systematic review and thematic synthesis of patient experiences in qualitative studies","volume":"34","author":"Breeksema","year":"2020","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.euroneuro.2022.10.008_bib0013","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.pnpbp.2012.06.001","article-title":"Developments in harmine pharmacology\u2013implications for ayahuasca use and drug-dependence treatment","volume":"39","author":"Brierley","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"11","key":"10.1016\/j.euroneuro.2022.10.008_bib0014","doi-asserted-by":"crossref","DOI":"10.3390\/ph13110334","article-title":"Toxicokinetics and Toxicodynamics of Ayahuasca Alkaloids N, N -Dimethyltryptamine (DMT), Harmine, Harmaline and Tetrahydroharmine: Clinical and Forensic Impact","volume":"13","author":"Brito-da-Costa","year":"2020","journal-title":"Pharmaceuticals"},{"issue":"9","key":"10.1016\/j.euroneuro.2022.10.008_bib0015","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.psyneuen.2005.02.010","article-title":"Depression and cortisol responses to psychological stress: a meta-analysis","volume":"30","author":"Burke","year":"2005","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.euroneuro.2022.10.008_sbref0016","series-title":"Atmos. Pollut. For. Areas: Their Deposition Interception, [Proc. Symp.], 2nd","article-title":"Biden administration plans for legal psychedelic therapies within two years","author":"Busby","year":"2022"},{"issue":"4","key":"10.1016\/j.euroneuro.2022.10.008_bib0017","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/02791072.1998.10399712","article-title":"Ayahuasca preparations and serotonin reuptake inhibitors: a potential combination for severe adverse interactions","volume":"30","author":"Callaway","year":"1998","journal-title":"J. Psychoact. Drugs"},{"issue":"10","key":"10.1016\/j.euroneuro.2022.10.008_bib0018","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1021\/acschemneuro.8b00101","article-title":"Dark Classics in Chemical Neuroscience: N, N-Dimethyltryptamine (DMT)","volume":"9","author":"Cameron","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0019","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3389\/fphar.2018.00561","article-title":"Ayahuasca and its DMT-and \u03b2-carbolines\u2013containing ingredients block the expression of ethanol-induced conditioned place preference in mice: Role of the treatment environment","volume":"9","author":"Cata-Preta","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.euroneuro.2022.10.008_bib0020","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s11011-020-00547-w","article-title":"Toxicity of ayahuasca after 28 days daily exposure and effects on monoamines and brain-derived neurotrophic factor (BDNF) in brain of Wistar rats","volume":"35","author":"Cola\u00e7o","year":"2020","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0021","first-page":"50","article-title":"An ontogenic study of the behavioral effects of chronic intermittent exposure to ayahuasca in mice","author":"Correa-Netto","year":"2017","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0022","first-page":"1","article-title":"Is Ayahuasca an option for the treatment of crack cocaine dependence?","author":"Cruz","year":"2018","journal-title":"J. Psychoactive Drugs"},{"issue":"4","key":"10.1016\/j.euroneuro.2022.10.008_bib0023","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1590\/1516-4446-2018-0140","article-title":"Acute antidepressant effect of ayahuasca in juvenile non-human primate model of depression","volume":"41","author":"da Silva","year":"2019","journal-title":"Braz J Psychiatry"},{"issue":"2","key":"10.1016\/j.euroneuro.2022.10.008_bib0024","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/02791072.2005.10399792","article-title":"Ayahuasca in adolescence: a preliminary psychiatric assessment","volume":"37","author":"Da Silveira","year":"2005","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0025","doi-asserted-by":"crossref","first-page":"e2727","DOI":"10.7717\/peerj.2727","article-title":"Harmine stimulates proliferation of human neural progenitors","volume":"4","author":"Dakic","year":"2016","journal-title":"PeerJ"},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2022.113878","article-title":"Effects of repeated ayahuasca administration on behaviour and c-Fos expression in male rats exposed to the open field","volume":"427","author":"Daldegan-Bueno","year":"2022","journal-title":"Behav. Brain Res."},{"issue":"6","key":"10.1016\/j.euroneuro.2022.10.008_bib0027","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1007\/s00213-022-06063-2","article-title":"Ayahuasca and tobacco smoking cessation: results from an online survey in Brazil","volume":"239","author":"Daldegan-Bueno","year":"2022","journal-title":"Psychopharmacology (Berl.)"},{"issue":"7","key":"10.1016\/j.euroneuro.2022.10.008_bib0028","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1080\/10826084.2022.2063896","article-title":"Psychosocial and drug use assessment of regular vs. non-regular Ayahuasca users in a Brazilian Sample: a Web-Based Survey","volume":"57","author":"Daldegan-Bueno","year":"2022","journal-title":"Subst. Use Misuse"},{"issue":"4","key":"10.1016\/j.euroneuro.2022.10.008_bib0029","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41591-022-01744-z","article-title":"Increased global integration in the brain after psilocybin therapy for depression","volume":"28","author":"Daws","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0030","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.3389\/fpsyg.2019.01234","article-title":"Modulation of serum brain-derived neurotrophic factor by a single dose of Ayahuasca: observation from a randomized controlled trial","volume":"10","author":"de Almeida","year":"2019","journal-title":"Front. Psychol."},{"issue":"11","key":"10.1016\/j.euroneuro.2022.10.008_bib0031","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1002\/hbm.21381","article-title":"Seeing with the eyes shut: neural basis of enhanced imagery following ayahuasca ingestion","volume":"33","author":"de Araujo","year":"2012","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0032","series-title":"The Serotonin Receptors","first-page":"277","article-title":"Cellular and subcellular localization of serotonin receptors in the central nervous system","author":"Descarries","year":"2006"},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0033","series-title":"Ayahuasca Healing and Science","first-page":"63","article-title":"Ayahuasca and psychotherapy: Beyond integration","author":"Diament","year":"2021"},{"issue":"1","key":"10.1016\/j.euroneuro.2022.10.008_bib0034","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/mdc3.12242","article-title":"Banisteriopsis caapi, a Forgotten Potential Therapy for Parkinson's Disease?","volume":"3","author":"Djamshidian","year":"2016","journal-title":"Mov. Disord. Clin. Pract."},{"issue":"2","key":"10.1016\/j.euroneuro.2022.10.008_bib0035","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/02791072.2005.10399794","article-title":"Report on psychoactive drug use among adolescents using ayahuasca within a religious context","volume":"37","author":"Doering-Silveira","year":"2005","journal-title":"J. Psychoactive Drugs"},{"issue":"Pt 1","key":"10.1016\/j.euroneuro.2022.10.008_bib0036","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.brainresbull.2016.03.002","article-title":"Ayahuasca: Pharmacology, neuroscience and therapeutic potential","volume":"126","author":"Dom\u00ednguez-Clav\u00e9","year":"2016","journal-title":"Brain Res. Bull."},{"issue":"2","key":"10.1016\/j.euroneuro.2022.10.008_bib0037","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00213-018-5085-3","article-title":"Ayahuasca improves emotion dysregulation in a community sample and in individuals with borderline-like traits","volume":"236","author":"Dom\u00ednguez-Clav\u00e9","year":"2019","journal-title":"Psychopharmacology (Berl.)"},{"issue":"1","key":"10.1016\/j.euroneuro.2022.10.008_bib0038","doi-asserted-by":"crossref","first-page":"e2807","DOI":"10.1002\/hup.2807","article-title":"Ayahuasca may help to improve self-compassion and self-criticism capacities","volume":"37","author":"Dom\u00ednguez-Clav\u00e9","year":"2022","journal-title":"Hum. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.euroneuro.2022.10.008_bib0039","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1080\/02791072.2013.763564","article-title":"Safety and side effects of ayahuasca in humans\u2013an overview focusing on developmental toxicology","volume":"45","author":"dos Santos","year":"2013","journal-title":"J. Psychoactive Drugs"},{"issue":"12","key":"10.1016\/j.euroneuro.2022.10.008_bib0040","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1177\/0269881116652578","article-title":"The current state of research on ayahuasca: A systematic review of human studies assessing psychiatric symptoms, neuropsychological functioning, and neuroimaging","volume":"30","author":"Dos Santos","year":"2016","journal-title":"J. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.euroneuro.2022.10.008_bib0041","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/2045125316689030","article-title":"Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies","volume":"7","author":"Dos Santos","year":"2017","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0042","doi-asserted-by":"crossref","first-page":"901","DOI":"10.2147\/RMHP.S300656","article-title":"The use of classic hallucinogens\/psychedelics in a therapeutic context: healthcare policy opportunities and challenges","volume":"14","author":"Dos Santos","year":"2021","journal-title":"Risk Manag. Healthc. Policy"},{"issue":"5","key":"10.1016\/j.euroneuro.2022.10.008_bib0043","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/JCP.0000000000001428","article-title":"Ayahuasca Improves Self-perception of Speech Performance in Subjects With Social Anxiety Disorder: A Pilot, Proof-of-Concept, Randomized, Placebo-Controlled Trial","volume":"41","author":"Dos Santos","year":"2021","journal-title":"J. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.euroneuro.2022.10.008_bib0044","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00213-011-2434-x","article-title":"Pharmacology of ayahuasca administered in two repeated doses","volume":"219","author":"Dos Santos","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.euroneuro.2022.10.008_bib0045","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1590\/1516-4446-2015-1701","article-title":"Antidepressive and anxiolytic effects of ayahuasca: a systematic literature review of animal and human studies","volume":"38","author":"Dos Santos","year":"2016","journal-title":"Braz. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2022.10.008_bib0046","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1590\/0101-60830000000149","article-title":"Long-term effects of ayahuasca in patients with recurrent depression: a 5-year qualitative follow-up","volume":"41","author":"dos Santos","year":"2018","journal-title":"Rev. Psiquiatr. Clin."},{"issue":"6","key":"10.1016\/j.euroneuro.2022.10.008_bib0047","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/JCP.0b013e31823607f6","article-title":"Autonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine","volume":"31","author":"Dos Santos","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0048","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1590\/1516-4446-2020-0913","article-title":"Risk assessment of ayahuasca use in a religious context: self-reported risk factors and adverse effects","volume":"43","author":"Durante","year":"2020","journal-title":"Braz. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.euroneuro.2022.10.008_bib0049","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s13659-019-0210-5","article-title":"Ayahuasca: uses, phytochemical and biological activities","volume":"9","author":"Estrella-Parra","year":"2019","journal-title":"Nat. Prod. Bioprospect."},{"issue":"3","key":"10.1016\/j.euroneuro.2022.10.008_bib0050","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.drugalcdep.2010.03.024","article-title":"Assessment of addiction severity among ritual users of ayahuasca","volume":"111","author":"Fabregas","year":"2010","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.euroneuro.2022.10.008_bib0051","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jep.2007.10.014","article-title":"Evaluation of the analgesic effect of alkaloid extract of Peganum harmala L.: possible mechanisms involved","volume":"115","author":"Farouk","year":"2008","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0052","series-title":"The Therapeutic Use of Ayahuasca","article-title":"Assessment of the psychotherapeutic effects of ritual ayahuasca use on drug dependency: A pilot study","author":"Fern\u00e1ndez","year":"2014"},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2019.104196","article-title":"Pre-clinical investigations of \u03b2-carboline alkaloids as antidepressant agents: a systematic review","volume":"137","author":"Ferraz","year":"2019","journal-title":"Fitoterapia"},{"issue":"4","key":"10.1016\/j.euroneuro.2022.10.008_bib0054","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/ptr.6017","article-title":"The effect of Banisteriopsis caapi (B. caapi) on the motor deficits in the MPTP-treated common marmoset model of Parkinson's disease","volume":"32","author":"Fisher","year":"2018","journal-title":"Phytother. Res."},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0055","first-page":"1","article-title":"Psychedelics as anti-inflammatory agents","author":"Flanagan","year":"2018","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2019.112532","article-title":"Purging and the body in the therapeutic use of ayahuasca","volume":"239","author":"Fotiou","year":"2019","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0057","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.psychres.2018.04.012","article-title":"Psychological variables implied in the therapeutic effect of ayahuasca: a contextual approach","volume":"264","author":"Franquesa","year":"2018","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0058","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fphar.2016.00035","article-title":"The therapeutic potentials of ayahuasca: possible effects against various diseases of civilization","volume":"7","author":"Frecska","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.euroneuro.2022.10.008_bib0059","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s00702-013-1024-y","article-title":"A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity","volume":"120","author":"Frecska","year":"2013","journal-title":"J. Neural Transm."},{"issue":"1","key":"10.1016\/j.euroneuro.2022.10.008_bib0060","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1360-0443.2006.01652.x","article-title":"Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids","volume":"102","author":"Gable","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0061","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fpsyt.2018.00185","article-title":"Cortisol modulation by Ayahuasca in patients with treatment resistant depression and healthy controls","volume":"9","author":"Galv\u00e3o","year":"2018","journal-title":"Front. Psychiatry"},{"issue":"10","key":"10.1016\/j.euroneuro.2022.10.008_bib0062","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1177\/0269881120936486","article-title":"Changes in inflammatory biomarkers are related to the antidepressant effects of Ayahuasca","volume":"34","author":"Galv\u00e3o-Coelho","year":"2020","journal-title":"J. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.euroneuro.2022.10.008_bib0063","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.brainresbull.2009.02.002","article-title":"Beyond amygdala: default mode network activity differs between patients with social phobia and healthy controls","volume":"79","author":"Gentili","year":"2009","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0064","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114865","article-title":"Ayahuasca blocks ethanol preference in an animal model of dependence and shows no acute toxicity","volume":"285","author":"Gianfratti","year":"2022","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.euroneuro.2022.10.008_bib0065","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1556\/2054.2021.00165","article-title":"Symptom specificity of ayahuasca's effect on depressive symptoms","volume":"5","author":"Gilbert","year":"2021","journal-title":"J. Psychedelic Stud."},{"issue":"5","key":"10.1016\/j.euroneuro.2022.10.008_bib0066","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1080\/02791072.2020.1789247","article-title":"Pilot evaluation of a residential drug addiction treatment combining traditional amazonian medicine, ayahuasca and psychotherapy on depression and anxiety","volume":"52","author":"Giovannetti","year":"2020","journal-title":"J. Psychoact. Drugs"},{"issue":"2","key":"10.1016\/j.euroneuro.2022.10.008_bib0067","first-page":"159","article-title":"Ayahuasca modifies amphetamine self ingestion and modifies anxiety and locomotor activity in adolescent rats","volume":"13","author":"Godinho","year":"2017","journal-title":"J Biol"},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0068","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3389\/fphar.2021.623923","article-title":"The shipibo ceremonial use of ayahuasca to promote well-being: an observational study","volume":"12","author":"Gonzalez","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.euroneuro.2022.10.008_bib0069","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00213-019-05446-2","article-title":"Therapeutic potential of ayahuasca in grief: a prospective, observational study","volume":"237","author":"Gonz\u00e1lez","year":"2020","journal-title":"Psychopharmacology (Berl.)"},{"issue":"3","key":"10.1016\/j.euroneuro.2022.10.008_bib0070","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1177\/0030222817710879","article-title":"Potential use of ayahuasca in grief therapy","volume":"79","author":"Gonz\u00e1lez","year":"2019","journal-title":"OMEGA-J. Death Dying"},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0071","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.neuroimage.2014.05.052","article-title":"The salience network is responsible for switching between the default mode network and the central executive network: replication from DCM","volume":"99","author":"Goulden","year":"2014","journal-title":"Neuroimage"},{"issue":"2","key":"10.1016\/j.euroneuro.2022.10.008_bib0072","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00005053-199602000-00004","article-title":"Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil","volume":"184","author":"Grob","year":"1996","journal-title":"J. Nerv. Ment. Dis."},{"issue":"2","key":"10.1016\/j.euroneuro.2022.10.008_bib0073","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/JCP.0000000000001343","article-title":"Acute psychological adverse reactions in first-time ritual Ayahuasca users: a prospective case series","volume":"41","author":"G\u00f3mez-Sousa","year":"2021","journal-title":"J. Clin. Psychopharmacol."},{"issue":"8","key":"10.1016\/j.euroneuro.2022.10.008_bib0074","article-title":"Evidence of health and safety in American members of a religion who use a hallucinogenic sacrament","volume":"14","author":"Halpern","year":"2008","journal-title":"Med. Sci. Monit."},{"issue":"2","key":"10.1016\/j.euroneuro.2022.10.008_bib0075","doi-asserted-by":"crossref","first-page":"108","DOI":"10.2174\/1570159X16666180125095902","article-title":"Ayahuasca: psychological and physiologic effects, pharmacology and potential uses in addiction and mental illness","volume":"17","author":"Hamill","year":"2019","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.euroneuro.2022.10.008_sbref0076","series-title":"Forbes","article-title":"Alberta To Be First Canadian Province To Regulate Psychedelics For Therapeutic Use","author":"Herrington","year":"2022"},{"issue":"3","key":"10.1016\/j.euroneuro.2022.10.008_bib0077","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/hup.1106","article-title":"Cognition and depression: the effects of fluvoxamine, a sigma-1 receptor agonist, reconsidered","volume":"25","author":"Hindmarch","year":"2010","journal-title":"Hum. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.euroneuro.2022.10.008_bib0078","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1080\/02791072.2018.1511878","article-title":"Therapeutic potential ascribed to Ayahuasca by users in the Czech Republic","volume":"50","author":"Hor\u00e1k","year":"2018","journal-title":"J. Psychoactive Drugs"},{"issue":"2","key":"10.1016\/j.euroneuro.2022.10.008_bib0079","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","article-title":"Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis","volume":"71","author":"Howren","year":"2009","journal-title":"Psychosom. Med."},{"issue":"1","key":"10.1016\/j.euroneuro.2022.10.008_bib0080","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s12264-016-0090-1","article-title":"A review of the functional and anatomical default mode network in schizophrenia","volume":"33","author":"Hu","year":"2017","journal-title":"Neurosci. Bull."},{"issue":"3","key":"10.1016\/j.euroneuro.2022.10.008_bib0081","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s11064-015-1661-7","article-title":"Chronic brain inflammation: the neurochemical basis for drugs to reduce inflammation","volume":"41","author":"Jarrott","year":"2016","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.euroneuro.2022.10.008_bib0082","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-61169-x","article-title":"Effects of ayahuasca on mental health and quality of life in na\u00efve users: A longitudinal and cross-sectional study combination","volume":"10","author":"Jim\u00e9nez-Garrido","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0083","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.112743","article-title":"Neuroprotective potential of Ayahuasca and untargeted metabolomics analyses: applicability to Parkinson's disease","volume":"255","author":"Katchborian-Neto","year":"2020","journal-title":"J. Ethnopharmacol."},{"issue":"4","key":"10.1016\/j.euroneuro.2022.10.008_bib0084","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/02791072.2009.10399767","article-title":"Experiences of encounters with ayahuasca\u2013\"the vine of the soul\"","volume":"41","author":"Kjellgren","year":"2009","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0085","first-page":"1","article-title":"Ayahuasca and Public Health II: Health Status in a Large Sample of Ayahuasca-Ceremony Participants in the Netherlands","author":"Kohek","year":"2022","journal-title":"J. Psychoactive Drugs"},{"issue":"12","key":"10.1016\/j.euroneuro.2022.10.008_bib0086","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.tins.2012.09.007","article-title":"The sigma-1 receptor: roles in neuronal plasticity and disease","volume":"35","author":"Kourrich","year":"2012","journal-title":"Trends Neurosci."},{"issue":"18","key":"10.1016\/j.euroneuro.2022.10.008_bib0087","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1007\/s00213-016-4377-8","article-title":"Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking","volume":"233","author":"Kuypers","year":"2016","journal-title":"Psychopharmacology (Berl.)"},{"issue":"2","key":"10.1016\/j.euroneuro.2022.10.008_bib0088","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.drugpo.2011.06.006","article-title":"Ayahuasca and the process of regulation in Brazil and internationally: implications and challenges","volume":"23","author":"Labate","year":"2012","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0089","series-title":"The Internationalization of Ayahuasca","author":"Labate","year":"2011"},{"issue":"5","key":"10.1016\/j.euroneuro.2022.10.008_bib0090","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/02791072.2017.1361559","article-title":"Nourishing the spirit: exploratory research on ayahuasca experiences along the continuum of recovery from eating disorders","volume":"49","author":"Lafrance","year":"2017","journal-title":"J. Psychoactive Drugs"},{"issue":"1","key":"10.1016\/j.euroneuro.2022.10.008_bib0091","doi-asserted-by":"crossref","first-page":"15201","DOI":"10.1038\/s41598-017-14700-6","article-title":"Well-being, problematic alcohol consumption and acute subjective drug effects in past-year ayahuasca users: a large, international, self-selecting online survey","volume":"7","author":"Lawn","year":"2017","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.euroneuro.2022.10.008_bib0092","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s10298-007-0266-y","article-title":"Ayahuasca central nervous system effects: behavioral study","volume":"5","author":"Lima","year":"2007","journal-title":"Phytotherapie"},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0093","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3389\/fnbeh.2018.00190","article-title":"It's tea time: interference of Ayahuasca brew on discriminative learning in zebrafish","volume":"12","author":"Lobao-Soares","year":"2018","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0094","series-title":"The Therapeutic Use of Ayahuasca","article-title":"Therapist and patient perspectives on ayahuasca-assisted treatment for substance dependence","author":"Loizaga-Velder","year":"2014"},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0095","series-title":"The Ethnopharmacology of Ayahuasca","article-title":"Indigenous and mestizo use of ayahuasca. An overview","author":"Luna","year":"2011"},{"issue":"11","key":"10.1016\/j.euroneuro.2022.10.008_bib0096","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","article-title":"Psychedelics promote structural and functional neural plasticity","volume":"23","author":"Ly","year":"2018","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.euroneuro.2022.10.008_bib0097","doi-asserted-by":"crossref","first-page":"e725","DOI":"10.1016\/j.jpainsymman.2022.01.024","article-title":"The therapeutic potential of psychedelic-assisted therapies for symptom control in patients diagnosed with serious illness: a systematic review","volume":"63","author":"Maia","year":"2022","journal-title":"J. Pain Symptom Manage."},{"issue":"3","key":"10.1016\/j.euroneuro.2022.10.008_bib0098","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1080\/02791072.2020.1854399","article-title":"The ritual use of ayahuasca during treatment of severe physical illnesses: a qualitative study","volume":"53","author":"Maia","year":"2021","journal-title":"J. Psychoact. Drugs"},{"issue":"9","key":"10.1016\/j.euroneuro.2022.10.008_bib0099","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/nn1971","article-title":"New insights into BDNF function in depression and anxiety","volume":"10","author":"Martinowich","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0100","series-title":"The Therapeutic Use of Ayahuasca","first-page":"217","article-title":"Postscript\u2014Psychedelics in unlocking the unconscious: From cancer to addiction","author":"Mat\u00e9","year":"2014"},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0101","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.688439","article-title":"Effects of ayahuasca on personality: results of two randomized, placebo-controlled trials in healthy volunteers","volume":"12","author":"Mendes Rocha","year":"2021","journal-title":"Front. Psychiatry"},{"issue":"3","key":"10.1016\/j.euroneuro.2022.10.008_bib0102","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1590\/S0104-93132013000300005","article-title":"A ayahuasca e o tratamento da depend\u00eancia","volume":"19","author":"Mercante","year":"2013","journal-title":"Mana"},{"issue":"2","key":"10.1016\/j.euroneuro.2022.10.008_bib0103","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1080\/02791072.2019.1674428","article-title":"Ayahuasca\u2019s antidepressant effects covary with behavioral activation as well as mindfulness","volume":"52","author":"Mian","year":"2020","journal-title":"J. Psychoactive Drugs"},{"issue":"1","key":"10.1016\/j.euroneuro.2022.10.008_bib0104","first-page":"65","article-title":"Antinociceptive effects of Peganum harmala L. alkaloid extract on mouse formalin test","volume":"7","author":"Monsef","year":"2004","journal-title":"J. Pharm. Pharm. Sci"},{"issue":"1","key":"10.1016\/j.euroneuro.2022.10.008_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41398-020-01011-0","article-title":"N, N-dimethyltryptamine compound found in the hallucinogenic tea ayahuasca, regulates adult neurogenesis in vitro and in vivo","volume":"10","author":"Morales-Garcia","year":"2020","journal-title":"Transl. Psychiatry"},{"issue":"5309","key":"10.1016\/j.euroneuro.2022.10.008_bib0106","article-title":"The alkaloids of Banisteriopsis caapi, the plant source of the Amazonian hallucinogen Ayahuasca, stimulate adult neurogenesis in vitro","volume":"7","author":"Morales-Garc\u00eda","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.euroneuro.2022.10.008_bib0107","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00213-019-05445-3","article-title":"Ayahuasca's \u2018afterglow\u2019: improved mindfulness and cognitive flexibility in ayahuasca drinkers","volume":"237","author":"Murphy-Beiner","year":"2020","journal-title":"Psychopharmacology (Berl.)"},{"issue":"10","key":"10.1016\/j.euroneuro.2022.10.008_bib0108","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1007\/s00213-020-05601-0","article-title":"Modulatory effects of ayahuasca on personality structure in a traditional framework","volume":"237","author":"Netzband","year":"2020","journal-title":"Psychopharmacology (Berl.)"},{"issue":"1","key":"10.1016\/j.euroneuro.2022.10.008_bib0109","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jphs.2014.12.005","article-title":"Role of sigma-1 receptors in neurodegenerative diseases","volume":"127","author":"Nguyen","year":"2015","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0110","series-title":"The Therapeutic Use of Ayahuasca","article-title":"Ayahuasca as a Candidate Therapy for PTSD","author":"Nielson","year":"2014"},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0111","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.alcohol.2019.10.005","article-title":"Effects of the hallucinogenic beverage ayahuasca on voluntary ethanol intake by rats and on cFos expression in brain areas relevant to drug addiction","volume":"84","author":"Nolli","year":"2020","journal-title":"Alcohol"},{"issue":"3","key":"10.1016\/j.euroneuro.2022.10.008_bib0112","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/02791072.2016.1188225","article-title":"Effects of Ayahuasca and its alkaloids on drug dependence: a systematic literature review of quantitative studies in animals and humans","volume":"48","author":"Nunes","year":"2016","journal-title":"J. Psychoactive Drugs"},{"issue":"6","key":"10.1016\/j.euroneuro.2022.10.008_bib0113","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1590\/S0102-695X2011005000170","article-title":"Neurobehavioral, reflexological and physical development of Wistar rat offspring exposed to ayahuasca during pregnancy and lactation","volume":"21","author":"Oliveira","year":"2011","journal-title":"Rev. Bras. Farmacogn."},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0114","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.physbeh.2015.01.032","article-title":"Effects of ayahuasca on the development of ethanol-induced behavioral sensitization and on a post-sensitization treatment in mice","volume":"142","author":"Oliveira-Lima","year":"2015","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0115","article-title":"Communalistic use of psychoactive plants as a bridge between traditional healing practices and Western medicine: A new path for the Global Mental Health movement","author":"Ona","year":"2021","journal-title":"Transcult. Psychiatry"},{"issue":"2","key":"10.1016\/j.euroneuro.2022.10.008_bib0116","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/02791072.2019.1567961","article-title":"Ayahuasca and public health: health status, psychosocial well-being, lifestyle, and coping strategies in a large sample of ritual ayahuasca users","volume":"51","author":"Ona","year":"2019","journal-title":"J. Psychoact. Drugs"},{"issue":"3","key":"10.1016\/j.euroneuro.2022.10.008_bib0117","doi-asserted-by":"crossref","first-page":"e2728","DOI":"10.1002\/hup.2728","article-title":"How does ayahuasca work from a psychiatric perspective? Pros and cons of the entheogenic therapy","volume":"35","author":"Orsolini","year":"2020","journal-title":"Hum. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.euroneuro.2022.10.008_bib0118","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1590\/1516-4446-2014-1496","article-title":"Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report","volume":"37","author":"Osorio","year":"2015","journal-title":"Braz. J. Psychiatry"},{"issue":"1-3","key":"10.1016\/j.euroneuro.2022.10.008_bib0119","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejphar.2012.01.030","article-title":"The sigma-1 receptor protects against cellular oxidative stress and activates antioxidant response elements","volume":"682","author":"Pal","year":"2012","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.euroneuro.2022.10.008_bib0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118143","article-title":"The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network","volume":"10","author":"Palhano-Fontes","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.euroneuro.2022.10.008_bib0121","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1017\/S0033291718001356","article-title":"Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial","volume":"49","author":"Palhano-Fontes","year":"2019","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0122","series-title":"Ayahuasca For the Treatment of Depression","first-page":"113","volume":"56","author":"Palhano-Fontes","year":"2022"},{"issue":"1","key":"10.1016\/j.euroneuro.2022.10.008_bib0123","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.rcp.2019.10.005","article-title":"Psychosis induced by abuse of ayahuasca: a case report","volume":"50","author":"Palma-\u00c1lvarez","year":"2021","journal-title":"Rev. Colomb. Psiquiatr."},{"issue":"6","key":"10.1016\/j.euroneuro.2022.10.008_bib0124","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1177\/0269881120909409","article-title":"Subacute effects of the psychedelic ayahuasca on the salience and default mode networks","volume":"34","author":"Pasquini","year":"2020","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.euroneuro.2022.10.008_bib0125","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/dar.13348","article-title":"Associations between ayahuasca consumption in naturalistic settings and current alcohol and drug use: Results of a large international cross-sectional survey","volume":"41","author":"Perkins","year":"2022","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0126","doi-asserted-by":"crossref","unstructured":"Perkins, D., Ruffell, S., Day, K., Pinzon, D. & Sarris, J. (2022b) Psychotherapeutic and neurobiological processes associated with ayahuasca's mental health and wellbeing outcomes: a proposed model and implications for therapeutic use. OSF Preprints February 14. doi:10.31219\/osf.io\/e5tjc.","DOI":"10.31219\/osf.io\/e5tjc"},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0127","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3389\/fphar.2021.623979","article-title":"Influence of context and setting on the mental health and wellbeing outcomes of ayahuasca drinkers: results of a large international survey","volume":"12","author":"Perkins","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0128","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.beproc.2015.05.004","article-title":"Behavioural and neurotoxic effects of ayahuasca infusion (Banisteriopsis caapi and Psychotria viridis) in female Wistar rat","volume":"118","author":"Pic-Taylor","year":"2015","journal-title":"Behav. Processes"},{"issue":"1","key":"10.1016\/j.euroneuro.2022.10.008_bib0129","first-page":"e17174","article-title":"Pre-clinical interaction of ayahuasca, a brew used in spiritual movements, with morphine and propofol","volume":"54","author":"Pires","year":"2018","journal-title":"J. Pharm. Sci."},{"issue":"11","key":"10.1016\/j.euroneuro.2022.10.008_bib0130","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1007\/s00213-020-05609-6","article-title":"Ayahuasca blocks the reinstatement of methylphenidate-induced conditioned place preference in mice: behavioral and brain Fos expression evaluations","volume":"237","author":"Reis","year":"2020","journal-title":"Psychopharmacology (Berl.)"},{"issue":"2","key":"10.1016\/j.euroneuro.2022.10.008_bib0131","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s40519-018-0619-6","article-title":"An exploratory study of experiences with conventional eating disorder treatment and ceremonial ayahuasca for the healing of eating disorders","volume":"25","author":"Renelli","year":"2020","journal-title":"Eat Weight Disord."},{"issue":"1","key":"10.1016\/j.euroneuro.2022.10.008_bib0132","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000077946","article-title":"Effects of the South American psychoactive beverage ayahuasca on regional brain electrical activity in humans: a functional neuroimaging study using low-resolution electromagnetic tomography","volume":"50","author":"Riba","year":"2004","journal-title":"Neuropsychobiology"},{"issue":"6","key":"10.1016\/j.euroneuro.2022.10.008_bib0133","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1046\/j.1365-2125.2002.01609.x","article-title":"Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers","volume":"53","author":"Riba","year":"2002","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.euroneuro.2022.10.008_bib0134","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s002130000606","article-title":"Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers","volume":"154","author":"Riba","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.euroneuro.2022.10.008_bib0135","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00213-006-0358-7","article-title":"Increased frontal and paralimbic activation following ayahuasca, the pan-Amazonian inebriant","volume":"186","author":"Riba","year":"2006","journal-title":"Psychopharmacology (Berl.)"},{"issue":"1","key":"10.1016\/j.euroneuro.2022.10.008_bib0136","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1124\/jpet.103.049882","article-title":"Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics","volume":"306","author":"Riba","year":"2003","journal-title":"J. Pharmacol. Exp. Ther"},{"issue":"4","key":"10.1016\/j.euroneuro.2022.10.008_bib0137","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00406-021-01267-7","article-title":"Effects of ayahuasca and its alkaloids on substance use disorders: an updated (2016\u20132020) systematic review of preclinical and human studies","volume":"272","author":"Rodrigues","year":"2022","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"9","key":"10.1016\/j.euroneuro.2022.10.008_bib0138","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1177\/0269881119855974","article-title":"Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory","volume":"33","author":"Roseman","year":"2019","journal-title":"J. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.euroneuro.2022.10.008_bib0139","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1080\/14740338.2022.2054988","article-title":"Ayahuasca, a potentially rapid acting antidepressant: focus on safety and tolerability","volume":"21","author":"Rossi","year":"2022","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0140","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.687615","article-title":"Ceremonial ayahuasca in amazonian retreats\u2014mental health and epigenetic outcomes from a six-month naturalistic study","volume":"12","author":"Ruffell","year":"2021","journal-title":"Front. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2022.10.008_bib0141","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jphs.2014.11.011","article-title":"The involvement of the sigma-1 receptor in neurodegeneration and neurorestoration","volume":"127","author":"Ruscher","year":"2015","journal-title":"J. Pharmacol. Sci."},{"issue":"9","key":"10.1016\/j.euroneuro.2022.10.008_bib0142","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/ijnp\/pyx036","article-title":"Assessing the psychedelic \u201cafter-glow\u201d in ayahuasca users: post-acute neurometabolic and functional connectivity changes are associated with enhanced mindfulness capacities","volume":"20","author":"Sampedro","year":"2017","journal-title":"Int. J. Neuropsychopharmacolog."},{"issue":"3","key":"10.1016\/j.euroneuro.2022.10.008_bib0143","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1057\/s41292-020-00222-4","article-title":"Vegetative value: promissory horizons of therapeutic innovation in the global circulation of ayahuasca","volume":"16","author":"Sanabria","year":"2021","journal-title":"Biosocieties"},{"issue":"1","key":"10.1016\/j.euroneuro.2022.10.008_bib0144","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/JCP.0000000000000436","article-title":"Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a SPECT study","volume":"36","author":"Sanches","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.euroneuro.2022.10.008_bib0145","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00002826-199110000-00002","article-title":"Banisterine and Parkinson's disease","volume":"14","author":"Sanchez-Ramos","year":"1991","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0146","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1590\/0101-60830000000130","article-title":"Ayahuasca: what mental health professionals need to know","volume":"44","author":"Santos","year":"2017","journal-title":"Arch. Clin. Psychiatry (S\u00e3o Paulo)"},{"issue":"3","key":"10.1016\/j.euroneuro.2022.10.008_bib0147","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jep.2007.04.012","article-title":"Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members","volume":"112","author":"Santos","year":"2007","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0148","article-title":"Ayahuasca use and reported effects on depression and anxiety symptoms: An international cross-sectional study of 11,912 consumers","volume":"4","author":"Sarris","year":"2021","journal-title":"J. Affect. Disord. Rep."},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0149","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3389\/fnbeh.2017.00139","article-title":"Behavioral changes over time following ayahuasca exposure in zebrafish","volume":"11","author":"Savoldi","year":"2017","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0150","doi-asserted-by":"crossref","DOI":"10.1177\/2050312113508389","article-title":"Ayahuasca and cancer treatment","volume":"1","author":"Schenberg","year":"2013","journal-title":"SAGE Open Med"},{"issue":"9","key":"10.1016\/j.euroneuro.2022.10.008_bib0151","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137202","article-title":"Acute Biphasic Effects of Ayahuasca","volume":"10","author":"Schenberg","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0152","doi-asserted-by":"crossref","DOI":"10.1177\/13634615211062962","article-title":"Overcoming epistemic injustices in the biomedical study of ayahuasca: Towards ethical and sustainable regulation","author":"Schenberg","year":"2022","journal-title":"Transcult. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2022.10.008_bib0153","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00213-021-06027-y","article-title":"Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review","volume":"239","author":"Schimmel","year":"2022","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.euroneuro.2022.10.008_bib0154","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1556-3537.2010.01028.x","article-title":"Subjective Theories about (Self-)Treatment with Ayahuasca","volume":"21","author":"Schmid","year":"2010","journal-title":"Anthropol Conscious"},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0155","series-title":"Plants of the Gods: Origins of Hallucinogenic Use","author":"Schultes","year":"1979"},{"issue":"3","key":"10.1016\/j.euroneuro.2022.10.008_bib0156","first-page":"127","article-title":"Effects of Banisteriopsis caapi extract on Parkinson's disease","volume":"5","author":"Serrano-Due\u00f1as","year":"2001","journal-title":"The Scientific Review of Alternative Medicine"},{"issue":"6","key":"10.1016\/j.euroneuro.2022.10.008_bib0157","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1073\/pnas.0812686106","article-title":"The default mode network and self-referential processes in depression","volume":"106","author":"Sheline","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0158","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3389\/fphar.2018.00224","article-title":"Four Weekly Ayahuasca Sessions Lead to Increases in \u201cAcceptance\u201d Capacities: A Comparison Study With a Standard 8-Week Mindfulness Training Program","volume":"9","author":"Soler","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.euroneuro.2022.10.008_bib0159","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00213-015-4162-0","article-title":"Exploring the therapeutic potential of Ayahuasca: acute intake increases mindfulness-related capacities","volume":"233","author":"Soler","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"issue":"8","key":"10.1016\/j.euroneuro.2022.10.008_bib0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106533","article-title":"Psychedelic N, N-dimethyltryptamine and 5-methoxy-N, N-dimethyltryptamine modulate innate and adaptive inflammatory responses through the sigma-1 receptor of human monocyte-derived dendritic cells","volume":"9","author":"Szabo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0161","series-title":"Ayahuasca: From the Amazon to the Global Village ICEERS","author":"S\u00e1nchez","year":"2015"},{"issue":"S 3","key":"10.1016\/j.euroneuro.2022.10.008_bib0162","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1055\/s-2004-832679","article-title":"A perspective on the new mechanism of antidepressants: neuritogenesis through sigma-1 receptors","volume":"37","author":"Takebayashi","year":"2004","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0163","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.drugpo.2017.02.017","article-title":"Ayahuasca's entwined efficacy: An ethnographic study of ritual healing from \u2018addiction\u2019","volume":"44","author":"Talin","year":"2017","journal-title":"Int. J. Drug Policy"},{"issue":"1","key":"10.1016\/j.euroneuro.2022.10.008_bib0164","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2174\/15733998113099990003","article-title":"Ayahuasca-assisted therapy for addiction: results from a preliminary observational study in Canada","volume":"6","author":"Thomas","year":"2013","journal-title":"Curr Drug Abuse Rev."},{"issue":"2","key":"10.1016\/j.euroneuro.2022.10.008_bib0165","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/02791072.2009.10399905","article-title":"Changes in spirituality among ayahuasca ceremony novice participants","volume":"41","author":"Trichter","year":"2009","journal-title":"J. Psychoactive Drugs"},{"issue":"10","key":"10.1016\/j.euroneuro.2022.10.008_bib0166","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1007\/s00213-018-4988-3","article-title":"Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution","volume":"235","author":"Uthaug","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"issue":"7","key":"10.1016\/j.euroneuro.2022.10.008_bib0167","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.euroneuro.2016.03.012","article-title":"Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans","volume":"26","author":"Valle","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.euroneuro.2022.10.008_bib0168","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-06854-0","article-title":"Shannon entropy of brain functional complex networks under the influence of the psychedelic Ayahuasca","volume":"7","author":"Viol","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.euroneuro.2022.10.008_bib0169","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-84746-0","article-title":"Examining changes in personality following shamanic ceremonial use of ayahuasca","volume":"11","author":"Weiss","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0170","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.euroneuro.2022.01.114","article-title":"LSD, afterglow and hangover: Increased episodic memory and verbal fluency, decreased cognitive flexibility","volume":"58","author":"Wie\u00dfner","year":"2022","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.euroneuro.2022.10.008_bib0171","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1556\/2054.2019.007","article-title":"A phenomenology of subjectively relevant experiences induced by ayahuasca in Upper Amazon vegetalismo tourism","volume":"3","author":"Wolff","year":"2019","journal-title":"J. Psychedelic Stud."},{"key":"10.1016\/j.euroneuro.2022.10.008_bib0172","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3389\/fphar.2019.01325","article-title":"The Impact of Ayahuasca on Suicidality: Results From a Randomized Controlled Trial","volume":"10","author":"Zeifman","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.euroneuro.2022.10.008_bib0173","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00213-020-05692-9","article-title":"Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial","volume":"238","author":"Zeifman","year":"2021","journal-title":"Psychopharmacology (Berl)"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X22008847?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X22008847?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T18:05:15Z","timestamp":1760378715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X22008847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":173,"alternative-id":["S0924977X22008847"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2022.10.008","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ayahuasca's therapeutic potential: What we know \u2013 and what not","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2022.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}